Angle Share Price (AGL)

Find Your Broker

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Angle Plc	LSE:AGL	London	Ordinary Share	GB0034330679	ORD 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	53.00p	21,641	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
52.00p		54.00p	53.00p	53.00p	53.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Support Services	0.63	-8.93	-10.09		76.0

Related Shares
Experian (EXPN), Ferguson (FERG), Nakama (NAK), Kellan Group (KLN)

Angle (AGL) Latest News

Angle News

Date	Time	Source	Headline
11/1/2019	14:05	UKREG	Angle PLC Second Price Monitoring Extn
11/1/2019	14:00	UKREG	Angle PLC Price Monitoring Extension
11/1/2019	11:05	UKREG	Angle PLC Second Price Monitoring Extn
11/1/2019	11:00	UKREG	Angle PLC Price Monitoring Extension
11/1/2019	09:05	UKREG	Angle PLC Second Price Monitoring Extn
11/1/2019	09:00	UKREG	Angle PLC Price Monitoring Extension
10/1/2019	17:05	ALNC	Angle Shares Jump As Parsortix System Used In New Cancer Treatment
10/1/2019	16:41	UKREG	Angle PLC Second Price Monitoring Extn
10/1/2019	16:36	UKREG	Angle PLC Price Monitoring Extension
10/1/2019	16:06	ALNC	*Angle's Parsortix Shows Exceptional Promise For Use In Human Cancer

More Angle News

Angle Takeover Rumours

Angle (AGL) Share Charts

1 Year Angle Chart

1 Month Angle Chart

Intraday Angle Chart

Angle (AGL) Discussions and Chat

Angle Forums and Chat

Date	Time	Title	Posts
21/1/2019	09:11	ANGLE 2016 – LIQUID BIOPSY TAKEOVER TARGET	11,068
28/8/2018	11:29	ANGLE plc (AGL) One to Watch	-
02/7/2018	11:06	Still time to look at Angle (AGL)	-
14/5/2018	08:44	ANGLE (AGL) Strategic Move	-
16/3/2017	20:00	ANGLE [12.75p] TARA*S SHARE OF THE DECADE "TARGET PRICE Ј100.00 PER SHARE."	3,646

Add a New Thread

Angle (AGL) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
10:13:14	52.55	10,000	5,255.00	O
09:51:32	53.75	3,500	1,881.25	O
09:50:43	53.56	5,000	2,678.00	O
09:49:16	53.56	186	99.62	O
08:58:23	52.50	2,955	1,551.38	O

View all Angle trades in real-time

Angle (AGL) Top Chat Posts

Date	Subject
21/1/2019 08:20	Angle Daily Update: Angle Plc is listed in the Support Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 53p. Angle Plc has a 4 week average price of 38.50p and a 12 week average price of 38p. The 1 year high share price is 76.50p while the 1 year low share price is currently 38p. There are currently 143,486,522 shares in issue and the average daily traded volume is 328,331 shares. The market capitalisation of Angle Plc is £76,047,856.66. Read Full Thread Reply
10/1/2019 16:35	sicilian_kan: Massively overbought for a device used in a mouse study. What's the benefit to AGL so far? A few single digit £1,000s in potential sales revenues of cartridges for a P1 clinical trial? Yet the share price goes up by over £40m? - for the device? The market has just valued the actual drug at about £1bn. At the mouse study stage!? Bonkers. Expecting a big fall tomorrow. Read Full Thread Follow Reply
21/12/2018 07:37	4legs: Incentives are all very well when earned. I don't feel they should be set up when the share price has fallen to a low. I know we have had lots of good news, though this has only had a temporary positive effect on the share price, which would seem to indicate something has been missing in the strategy. Hence I don't see why incentives are due at this stage. Hopefully we are nearing more permanent growth. Read Full Thread Follow Reply
10/12/2018 23:15	escapetohome: My warning of the “ false gimmick trend “ back in Jan 2016. Now nearly 3 years later the share price is far below where were then. No progress. 3 years of the same pilfering gabbering gibberish of pounds not pence. Yet we clearly still a pence company. I will repeat again, I would be over the moon with 70 p , this is a dithering company which failed to take the right step, which was to take on board a partner with deep pockets early on. escapetohome - 28 Jan 2016 - 09:06:10 - 608 of 10519 ANGLE 2016 – LIQUID BIOPSY TAKEOVER TARGET - AGL Once again be aware the market maker " false gimmick trend" . This time they will be operating the other direction manipulating the share down to confuse allinto selling. The reality is there is a step forward, and the share price deserves higher. 1 Read Full Thread Follow Reply
06/12/2018 10:46	alloa2003: Brexit is not helping sentiment but not the reason for AGL share price weakness. There is literally no interest in the stock at the moment - going to be news driven for some time to come until we see sales and profits. Might drift until it finds support. Read Full Thread Follow Reply
06/12/2018 10:34	toffeeman: Brexit has absolutely jack sh1t to do with AGL's share price. Read Full Thread Follow Reply
23/8/2018 17:49	andypar: I'm a huge fan of AGL. Simple, high margin, high barriers to entry. Here are a few of my thoughts. Dilution hell or screening heaven ? Are the collaborations already in place all set up for FDA approval,so the moment we get it then the revenue can start kicking in ? I don't want to be reading a year after FDA that they are trying to establish sales channels etc. If the revenue does not ramp up very quickly then there will be more shares issued and we will be back to the famous AIM story of Jam Tomorrow. The big $$$ takeover that we all hope for will only occur from a position of strength ie sales and a strong balance sheet. Otherwise we will be diluted into oblivion and maybe saved at the last by a takeover on the cheap. With our current cost base we need approx. $15m in revenue to breakeven. We need at least $5m in sales the year following FDA and it to double year on year thereafter. I want everything ready to go and all the trumpets blaring when we get FDA. If the share price doubles or triples post FDA approval do another capital raise then for say $25m (hopefully the last). Don't forget we will need to fund further trials to get approval from the FDA for other cancers. This should be considerably less arduous than it has been for the MBC. Also post FDA approval I want AGL start talking about blood test screening. That would put the share price into orbit (also less dilution etc). Big pharma and the city could not fail to see the potential $$$$$$. A trial of 100 apparently fit people over 65 to see if they could pick up CTC's in any of the subjects. If the trial gave positive results ie picked up CTC's in say 5 of the subjects and led to potentially earlier diagnnosis and treatment. It would add a lot of $$$$$ to the market cap, even if real life screening was still 10 years away. It is much easier to talk about a market cap of billions when AGL talks screening :o) Everyone understands screening and the potential $$$$$$$$$$$$$$. AGL would be mad once we have to FDA approval not to exploit this. Get the market cap up, get us off AIM. Put us in the shop window as the future of medicine. Read Full Thread Follow Reply
22/8/2018 16:47	mikepompeyfan: In the absence of significant buying market makers lower a share price to drum up buying interest. They make their money on the spread so do all they can to generate turnover. They don't care at what share price. As a news driven share the price will soon be up again when it comes. Read Full Thread Follow Reply
09/7/2018 10:25	jelenko: The question is how much would we charge for a license? I think good trial results and the share price would start to factor in FDA approval. Remember how quickly it raced to 79p on the Bart's prostate news last year. This time the magnitude of the rise would be greater, I think we all know that. I have a simple way of looking at the share price potential especially when we have a meaningful revenue number( at some future date) Every £10m in revenue @75% margin and 15 PE would equate to 79p share price. Every £100m in revenue £790p. The market is enormous and you would think that with FDA £100m should be easily attainable. Especially when the market size the company talks about is valued in £bilions. Read Full Thread Follow Reply
26/3/2018 08:17	alloa2003: I think AGL share price suffers from boredom at times between announcements. Very news driven as profitability is some way off. Read Full Thread Follow Reply
24/12/2017 11:06	alloa2003: Its that time of year - what are your predicitons for the AGL share price in 12 months? I will start at £2 a share :) Read Full Thread Follow Reply

Angle share price data is direct from the London Stock Exchange

Your Recent History

LSE

AGL

Angle

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190121 10:37:21